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Chemical derivatives of artemisinin, a sesquiterpene lactone produced by Artemisia
annua, are the active ingredient in the most effective treatment for malaria.
Comprehensive phytochemical analysis of two contrasting chemotypes of A. annua
resulted in the characterization of over 80 natural products by NMR, more than 20 of
which are novel and described here for the first time. Analysis of high- and low-artemisinin
producing (HAP and LAP) chemotypes of A. annua confirmed the latter to have a low
level of DBR2 (artemisinic aldehyde 111(13) reductase) gene expression. Here we show
that the LAP chemotype accumulates high levels of artemisinic acid, arteannuin B,
epi-deoxyarteannuin B and other amorpha-4,11-diene derived sesquiterpenes which
are unsaturated at the 11,13-position. By contrast, the HAP chemotype is rich in
sesquiterpenes saturated at the 11,13-position (dihydroartemisinic acid, artemisinin
and dihydro-epi-deoxyarteannunin B), which is consistent with higher expression levels
of DBR2, and also with the presence of a HAP-chemotype version of CYP71AV1
(amorpha-4,11-diene C-12 oxidase). Our results indicate that the conversion steps from
artemisinic acid to arteannuin B, epi-deoxyarteannuin B and artemisitene in the LAP
chemotype are non-enzymatic and parallel the non-enzymatic conversion of DHAA
to artemisinin and dihyro-epi-deoxyarteannuin B in the HAP chemotype. Interestingly,
artemisinic acid in the LAP chemotype preferentially converts to arteannuin B rather than
the endoperoxide bridge containing artemisitene. In contrast, in the HAP chemotype,
DHAA preferentially converts to artemisinin. Broader metabolomic and transcriptomic
profiling revealed significantly different terpenoid profiles and related terpenoid gene
expression in these two morphologically distinct chemotypes.
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INTRODUCTION
Chemical derivatives of the sesquiterpene lactone, artemisinin, such as: artesunate, artemether
or dihydroartemisinin are one of several active ingredients in artemisinin-combination therapies
(ACTs)—the most effective treatment for malaria currently available. Biosynthesis of artemisinin
occurs in specialized 10-celled biseriate glandular trichomes present on the leaves, stems
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and inflorescences of Artemisia annua (Duke and Paul, 1993;
Duke et al., 1994; Ferreira and Janick, 1995). Concentrations
of artemisinin can range from 0.01 to 1.4% of leaf dry
weight (Larson et al., 2013). The biosynthetic pathway from
artemisinin precursors has been fully elucidated over the
past decade (Figure 3C). It starts from the cyclization of
farnesyl pyrophosphate (FPP) to amorpha-4,11-diene (A-
4,11-D) by amorph-4,11-diene synthase (AMS) (Bouwmeester
et al., 1999; Mercke et al., 2000) followed by the three-step
oxidation of A-4,11-D by amorpha-4,11-diene C-12 oxidase
(CYP71AV1), to artemisinic alcohol (AAOH), artemisinic
aldehyde (AAA), and artemisinic acid (AA) (Ro et al.,
2006; Teoh et al., 2006). ADH1—NAD-dependent alcohol
dehydrogenase with specificity toward artemisinic alcohol plays
a role in the formation of artemisinic aldehyde in the
artemisinin pathway of A. annua (Paddon et al., 2013). The
ADH1 gene has been used to improve yields of artemisinic
acid production in yeast (Paddon et al., 2013). Artemisinic
aldehyde 111(13) reductase (DBR2) catalyzes the formation
of dihydroartemisinic aldehyde (DHAAA) from AAA (Zhang
et al., 2008). DHAAA is subsequently oxidized in the final
enzymatic reaction to dihydroartemisinic acid (DHAA) by
aldehyde dehydrogenase ALDH1 (Teoh et al., 2009). Genes
encoding all of these biosynthetic enzymes have been shown to
be highly expressed in apical and sub-apical cells of A. annua
glandular trichomes (Olsson et al., 2009; Soetaert et al., 2013).
Recent studies have revealed that the conversion of DHAA
to artemisinin and dihydro-epi-deoxyarteannuin B (DHEDB)
proceeds via a series of non-enzymatic and spontaneous
photochemical reactions, involving the highly reactive tertiary
allylic hydroperoxide of dihydroartemisinic acid, DHAAOOH
(Wallaart et al., 1999; Sy and Brown, 2002; Brown and Sy,
2004). Similarly, it has previously been proposed that AA
is photochemically converted to arteannuin B (ArtB) via the
tertiary allylic hydroperoxide of artemisinic acid (Brown and Sy,
2007).
Based on the content of artemisinin and its precursors,
two contrasting chemotypes of A. annua have been described:
a low-artemisinin production (LAP) chemotype and a high-
artemisinin production (HAP) chemotype (Wallaart et al., 2000).
Both chemotypes contain artemisinin, but the HAP chemotype
has a relatively high content of DHAA and artemisinin, whereas
the LAP chemotype has a high content of AA and ArtB
(Lommen et al., 2006; Arsenault et al., 2010; Larson et al.,
2013). Recent studies have concluded that a major factor in
determining the biochemical phenotype of HAPs and LAPs is
the differential expression of DBR2—with low expression in LAP
chemotypes correlating with a number of insertions/deletions
in the DBR2 promoter sequence (Yang et al., 2015). We
have recently shown that the overall pathway to artemisinin
biosynthesis is under strict developmental control with early
steps in the pathway occurring in young leaves and later steps
in mature leaves (Czechowski et al., 2016). In the present
study, we have used both metabolomics and transcriptomics
to investigate the developmental regulation of sesquiterpene
biosynthesis in HAP and LAP chemotypes. Using a combination
of NMR and UPLC-/GC-MS techniques we have characterized a
number of amorphane and cadinane sesquiterpenes in addition
to other terpenes isolated from leaf glandular trichomes.
We have also extended the transcript analysis in HAPs
and LAPs beyond the genes encoding artemisinin-pathway
enzymes. Our findings suggest profound differences in general
terpenoid metabolism between HAP and LAP chemotypes that
extend well beyond altered DBR2 expression and artemisinin
content.
MATERIALS AND METHODS
Plant Material
Artemis is an F1 hybrid variety of A. annua developed by
Mediplant (Conthey, Switzerland), produced by crossing C4
and C1 parental material of East Asian origin (Delabays
et al., 2001). Artemisinin content has been reported to
reach 1.4% of the leaf dry weight when grown in the
field, and its metabolite profile is typical for the HAP
chemotype (Larson et al., 2013). NCV (“non-commercial
variety”), an “open-pollinated” variety of European origin was
also provided by Mediplant, and has the lowest reported
artemisinin content from any A. annua germplasm in addition
to a metabolite profile characteristic of the LAP chemotype
(Larson et al., 2013). Plants were grown from seeds in
glasshouse conditions as previously described (Graham et al.,
2010).
Leaf Area Measurements
The leaf area of glasshouse-grown plants was measured by
scanning for leaves 14–16 (counting from the apical meristem),
followed by calculation of the leaf area using LAMINA software
(Bylesjö et al., 2008).
Trichome Density Measurements
Trichome density was quantified on the abaxial surface of
the terminal leaflets of leaves 14–16 (counting from the
apical meristem). Trichomes were visualized using a Zeiss
fluorescent dissecting microscope (fitted with a 470/40 nm
excitation filter/ 525/50 nm emission filter). Images were
recorded using AxioVision 4.7 software (Carl Zeiss Ltd.
Herts., UK). Trichome number was counted manually
across a 3 × 0.5 mm2 leaflet sample area and the average
(mean) trichome density was then calculated for the whole
leaf.
NMR Structural Data for Natural
Compounds From Artemis and NCV
Leaf and stem material from Artemis (5 Kg) was extracted
in CHCl3 (20 L). The organic solvent was removed by rotary
evaporation and a portion of the residual dark green aromatic
plant extract (ca 2.5% w/w) was “dry-loaded” on to a silica
column for gradient column chromatography (see Table section
Gradient Column Chromatography of the Artemis Variety of A.
annua).
Frontiers in Plant Science | www.frontiersin.org 2 May 2018 | Volume 9 | Article 641
Czechowski et al. Comparative Analysis of Artemisia Chemotypes
Gradient Column Chromatography of the Artemis
Variety of A. annua
Solvent Fraction
10% EtOAc/hexane A, B∗, C and D∗
20% EtOAc/hexane E, F, G, H, I and J
30% EtOAc/hexane K, L, M, N and O∗
50% EtOAc/hexane P and Q
EtOAc R, S, T∗, U and V
Methanol W, X and Y
Each of the fractions A-Y from gradient column
chromatography of Artemis were then further purified by
isocratic preparative normal-phase HPLC (∗fractions B, D, I,
O, and T were also subjected to a second round of isocratic
column chromatography prior to prep. HPLC); and individual
metabolites were then characterized by NMR, as listed in
Figure 1A and the Supplemental Table 1 (1D- and 2D-NMR
data for all metabolites is also given in the Supplementary
List 1). Selected fractions were analyzed by UPLC-APCI-
high resolution MS to verify molecular weights and chemical
formulae. Confirmed annotations were used to update m/z
and retention time reference data, to enable reporting of these
compounds from plant extracts by UPLC-MS.
Leaf and stem material from the NCV variety of A. annua
(780 g) was extracted in CHCl3 (4 L). The organic solvent was
then removed by rotary evaporation and the residual dark green
aromatic plant extract (16.6 g; ca 2% w/w) was dry-loaded onto
a silica column for gradient column chromatography (see Table
section Gradient Column Chromatography of the NCV Variety
of A. annua).
Gradient Column Chromatography of the NCV Variety
of A. annua
Solvent Fraction
2% EtOAc/hexane A, B and C
10% EtOAc/hexane D, E, F and G
20% EtOAc/hexane G, H and I
40% EtOAc/hexane J, K and L
EtOAc M and N
Methanol N
Each of the fractions A-N from gradient column
chromatography of NCV were then further purified by isocratic
preparative normal-phase HPLC; individual metabolites
were then characterized by NMR, as listed in Figure 1B and
the Supplemental Table 1 (1D- and 2D-NMR data for all
metabolites are also given in the Supplementary List 2). Selected
fractions were analyzed by UPLC-APCI-high resolution MS to
verify molecular weights and chemical formulae. Confirmed
annotations were used to update m/z and retention time
reference data, to enable reporting of these compounds from
plant extracts by UPLC-MS.
Metabolite Analysis by UPLC-MS and
GC-MS
Metabolite analysis by UPLC- and GC-MS were performed as
described previously (Czechowski et al., 2016). Fifteen plants
from each of five genotype classes were grown from seeds in
4-inch pots under 16 h days for 12 weeks. Metabolite profiles
were generated from 50mg fresh weight (FW) pooled samples
of leaves collected at two different developmental stages: 1–5
(counted from the apical meristem), representing the juvenile
stage; and leaves 11–13, representing the mature, expanded stage
(Figure 3A). Fresh leaf samples were stored at −80◦C, pending
analysis. In addition, dry leaf material was also obtained from 14-
week old plants, cut just above the zone of senescing leaves, and
dried for 14 days at 40◦C. Leaves were stripped from the plants,
and leaf material sieved through 5mm mesh to remove small
stems. Trichome-specific metabolites were extracted as described
previously (Czechowski et al., 2016) with minor modifications.
Briefly, 50mg of fresh material was extracted by gentle shaking
in 500 µl chloroform for 1 h. Supernatant was taken out
and remaining plant material was fully dried in a centrifugal
evaporator (GeneVac R© Ez-2 plus, Genevac Ltd, Ipswich, UK).
Weight of the extracted and dried material was taken and used
to quantify abundance of the specific compounds per unit of
extracted dry weight. Dry leaf material (0.5 g) was ground to a
fine powder using a TissueLyser II ball mill fitted with stainless
steel grinding jars (Qiagen, Crawley, UK) operated at 25Hz for
1min. Ten mg sub-samples of dry leaf material were extracted in
9:1 (v/v) chloroform:ethanol with gentle shaking for 1 h and then
analyzed as per fresh material.
For UPLC-MS analysis of sesquiterpenes, a diluted (1:5
(v/v) extract:ethanol) 2 µL aliquot was injected on an Acquity
UPLC system (Waters, Elstree, UK) fitted with a Luna 50 ×
2mm 2.5µm HST column (Phenomenex, Macclesfield, UK).
Metabolites were eluted at 0.6 mL/min and 60◦C using a linear
gradient from 60 to 100% A:B over 2.5min, where A = 5% (v/v)
aqueous MeOH and B = MeOH, with both A and B containing
0.1% (v/v) formic acid. Pseudomolecular [M+H]+ ions were
detected using a Thermo Fisher LTQ-Orbitrap (ThermoFisher,
Hemel Hempstead, UK) mass spectrometer fitted with an
atmospheric pressure chemical ionization source operating in
positive ionization mode under the control of Xcalibur 2.1
software. Data was acquired over the m/z range 100–1,000 in
FTMS centroid mode with resolution set to 7500 FWHM at
m/z 400. Data extraction and analysis was performed using
packages and custom scripts in R 3.2.2 (https://www.R-project.
org/). XCMS (Smith et al., 2006) incorporating the centWave
algorithm (Tautenhahn et al., 2008) was used for untargeted
peak extraction. Deisotoping, fragment and adduct removal was
performed using CAMERA (Kuhl et al., 2012). Artemisinin
was quantified using the standard curve of the response ratio
of artemisinin (Sigma, Poole, UK) to internal standard (β-
artemether; Hallochem Pharmaceutical, Hong Kong) that was
previously added to extracts and standards. Metabolites were
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FIGURE 1 | Novel natural compounds characterized from the Artemis (A) and NCV (B) varieties of A. annua by the NMR approach. Numbering of compounds is
consistent with Supplementary Lists 1 and 2. Numbering of carbon atoms showed.
identified with reference to authentic standards or NMR-resolved
structures and empirical mass formulae calculated using the R
package rcdk (Guha, 2007) within 10 ppm error and elemental
constraints of: C= 1–100, H= 1–200, O= 0–20, N= 0–1. Peak
concentrations were calculated using bracketed response curves,
where standard curves were run every ∼30 samples. Metabolite
concentrations were expressed as a proportion of the residual dry
leaf material following extraction.
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FIGURE 2 | Ten pairs of 11,13-dihdyro/ 11,13-dehydro amorphanolides between Artemis (left-hand side) and NCV (right-hand side) varieties of A. annua
characterized by the NMR approach. Numbering of compounds is consistent with Supplementary Lists 1, 2. Numbering of carbon atoms showed. Novel compound
indicated by asterisk.
For analysis of monoterpenes and volatile sesquiterpenes from
fresh leaf samples, an aliquot of chloroform extract (prior to
dilution with ethanol for UPLC analysis) was taken for GC-MS
analysis using an Agilent 6890 GC interfaced to a Leco Pegasus IV
TOF MS (Leco, Stockport, UK). A 1 µL aliquot was injected into
a CIS4 injector (Gerstel, Mülheim an der Ruhr, Germany) fitted
Frontiers in Plant Science | www.frontiersin.org 5 May 2018 | Volume 9 | Article 641
Czechowski et al. Comparative Analysis of Artemisia Chemotypes
FIGURE 3 | Metabolic and transcriptomic comparison of the artemisinin pathway in the low- vs. high-artemisinin chemotypes of A. annua. (A) Level of selected
sesquiterpenes were quantified by GC-MS (i) and UPLC-MS (ii–vii) in fresh juvenile leaf 1–5 (Top), fresh mature leaf 11–13 (Mid.) and oven-dried whole plant-stripped
leaves (Dry) from 12-weeks old glasshouse-grown Artemis (green bars) and NCV (gray bars) varieties as described in Materials and methods. error bars—SEM (n = 15
for Top and Mid. leaf; n = 6 for Dry leaf). Letters represent Tukey’s range test results after one way ANOVA or REML (see Materials and Methods for details). Groups
not sharing letters indicate statistically significant differences. (B) Transcript profiling of enzymes involved in the artemisinin biosynthetic pathway, in two types of leaf
material as on (A) was done as described in Materials and Methods, error bars—SE (n = 9). Asterisk indicates t-test statically significant difference between Artemis
(green bars) and NCV (gray bars) at p < 0.05. (C) Summary of the metabolite and transcriptional differences between Artemis and NCV for the artemisinin biosynthetic
pathway: full arrows—known enzymatic steps, dashed arrows—non-enzymatic conversions, red arrows—transcript changes in juvenile leaves of NCV vs. Artemis,
green arrows—metabolite changes of NCV vs. Artemis (all types of leaves). DBR2 position in the pathway highlighted in a square. Metabolite abbreviations: G-3-P,
glyceraldehyde-3-phosphate; MEP, 2-C-methylerythritol 4-phosphate; MEcPP, 2-C-methyl-D-erythritol-2,4-cyclopyrophosphate. Cytosolic precursors: HMG-CoA,
3-hydroxy-3-methylglutaryl-CoA; MVA, mevalonate; IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl pyrophosphate; FPP, farnesyl pyrophosphate; A-4,11-D,
amorpha-4,11-diene; AAOH, artemsinic alcohol; AAA, artemsinic aldehyde; AA, artemsinic acid; ArtB, arteannuin B; DHAAA - dihydroartemsinic aldehyde; DHAA,
dihydroartemsinic acid; DHAAOOH, dihydroartemsinic acid tertiary hydroperoxide; DHEDB, dihydro-epi-deoxyarteanniun B; AAOOH, artemsinic acid tertiary
hydroperoxide; EDB, epi-deoxyarteannuin B. Enzyme abbreviations: HMGR-, 3-hydroxy-3-methylglutaryl coenzyme A reductase; HDR-,
4-hydroxy-3-methylbut-2-enyl diphosphate reductase; DXR, 1-deoxy-D-xylulose-5-phosphate reductoisomerase; DXS-, 1-deoxy-D-xylulose-5-phosphate synthase;
FPS, farnesyl diphosphate synthase. AMS, amorpha-4,11-diene synthase; CYP71AV1, amorpha-4,11-diene C-12 oxidase; CPR, cytochrome P450 reductase; DBR2,
artemisinic aldehyde 1 11 (13) reductase; ALDH1, aldehyde dehydrogenase.
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FIGURE 4 | Principal component analysis of UPLC-MS (A) and GC-MS (B) data from different leaf types from Artemis and NCV varieties. Principal component
analysis of 75 UPLC-MS identified peaks (A) and 202 GC-MS identified metabolites (B). Leaf types, corresponding with Figure 3 are represented by symbols:
circles—leaf 1–5, triangles—leaf 11–13, crosshairs—oven-dried leaf. Two chemotypes represented by colors green—Artemis and gray—NCV. PCA was performed on
log-scaled data and mean-centered data; dotted ellipse = Hotelling’s 95% confidence interval.
FIGURE 5 | Heatmaps of influential metabolites from UPLC- and GC-MS PCA analyses. Top-n [UPLC-MS = 18 (A); GC-MS = 20 (B)] metabolites were chosen for
visualization based on loadings plots (Supplementary Figure 1) from the PC1 dimensions in the PCA analyses (Supplementary Figure 1). Mean data were log-scaled
and then row-scaled for color intensity plotting (lighter = more abundant). Hierarchical clustering was performed with average linkage, with Euclidean distances for
genotypes and 1-absolute values of correlations as distances for metabolites. Metabolite names are abbreviated where necessary for clarity and are given in full in
Supplementary Tables 2, 3.
with a 2mm ID glass liner containing deactivated glass wool at
10◦C. The injector was ramped from 10 to 300◦C at 12◦C/s then
held at 300◦C for 5min. The carrier gas was He at a constant
flow of 1 mL/min and the injection split ratio was 1:10. Peaks
were eluted using a Restek Rxi-5Sil MS column, 30m× 0.25mm
ID × 0.25µm film thickness (Thames Restek, Saunderton, UK).
The following temperature gradient was used: isothermal 40◦C
2min; ramp at 20◦C/min to 320◦C then hold for 1min; total run
time∼20min. The transfer line was maintained at 250◦C and the
MS used to collect−70 eV EI scans over the m/z range 20–450
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FIGURE 6 | Morphological characterization of low- and high-artemisinin natural chemotypes of A. annua. (A) Photographs show four representative 12-week old
plants from each two chemotypes of A. annua, ruler scaled in cm showed on both sides; Plant height (B), internode length (C), leaf area (D), and glandular secretory
trichome density (E) recorded for 12-week old plants. Green bars represent Artemis (HAP-chemotype) and brown bars represent NCV (LAP-chemotype). Error
bars—SEM (n = 15), letters represent one-way ANOVA Tukey’s range test results; Groups not sharing letters indicate statistically significant differences.
at a scan rate of 20 spectra/s. Acquisition was controlled by
ChromaTof 4.5 software (Leco). ChromaTof was used to identify
peaks and deconvolute spectra from each run, assuming a peak
width of 3 s and aminimum s/n of 10. Peak areas were reported as
deconvoluted total ion traces (DTIC). Further analyses including
annotation against authentic standards, between-sample peak
alignment, grouping, consensus DTIC reporting, and missing
value imputation were performed using custom scripts in R.
R was used for all statistical data analysis using the stats base
package, nlme (http://CRAN.R-project.org/package=nlme) and
pcaMethods (Stacklies et al., 2007).
RNA Isolation, cDNA Synthesis, and
Quantitative RT-PCR
Leaf tissue from juvenile and mature-stage leaves sampled
as described above was ground to a fine powder using
Qiagen Retsch MM300 TissueLyser (Qiagen, Hilden, Germany)
and total RNA extracted using the RNAeasy kit (Qiagen,
Hilden, Germany). RNA was quantified using NanoDrop-1000
(NanoDrop products, Wilmington, USA) and integrity was
checked on 2200 Tape Station Instrument (Agilent, Santa Clara,
CA, USA). Only samples scoring RIN number ≥7.0 were taken
for further analysis. Removal of genomic DNA was performed
by treating with TURBO DNA-free
TM
(Life Technologies Ltd,
Paisley, UK) following manufacturer’s instructions. 5 ug of
total RNA, pooled from 4 individual plants, representing 3
biological replicates, was reversely transcribed using SuperScript
II kit (Life Technologies Ltd, Paisley, UK) and Oligo(dT)12-
18 Primer (Life Technologies Ltd, Paisley, UK) according to
manufacturer’s instructions. PCR using primers (AMS_Ex4 for
5′-GGCTGTCTCTGCACCTCCTC-3′, AMS_Ex5 for 5′- CAG
CCATCAATAACGGCCTTG-3′) designed spanning intron 4 of
the AMS gene (GenBank: AF327527). Only samples that resulted
in amplification of the 251 bp fragment from cDNA and not
the 363 bp fragment from genomic DNA were taken for further
qPCR analysis.
Expression levels of amorpha-4,11-diene synthase (AMS),
amorpha-4,11-diene C-12 oxidase (CYP71AV1), cytochrome
P450 reductase (CPR), artemisinic aldehyde 1 11 (13) reductase
(DBR2) and aldehyde dehydrogenase (ALDH1), relative to
ubiquitin (UBI) were determined by qPCR. Reactions were run in
3 technical replicates. Gene-specific primers used were: AMS for
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5′- GGGAGATCAGTTTCTCATCTATGAA- 3′; AMS_Rev 5′-
CTTTTAGTAGTTGCCGCACTTCTT-3′; 5′ALDH1 for 5′- GAT
GTGTGTGGCAGGGTCTC-3′; ALDH1_Rev 5- ACGAGTGGC
GAGATCAAAAG-3′; CYP71AV1 for 5′- TCAACTGGAAAC
TCCCCAvcATG-3′; CYP71AV1_Rev 5′- CGGTCATGTCGA
TCTGGTCA-3′; CPR_For 5′- GCTCGGAACAGCCATCTTATT
CTT-3′, CPR_Rev 5′- GAAGCCTTCTGAGTCATCTTGTGT-3′,
DBR2 for 5′- GAACGGACGAATATGGTGGG-3′; DBR2_Rev
5′- GCAGTATGAATTTGCAGCGGT-3′, UBI for 5′-TGATTG
GCGTCGTCTTCGA-3′ and UBI_Rev 5′-CCCATCCTCCAT
TTCTAGCTCAT-3′. Reactions conditions and qPCR analysis
were performed as above, 1 ul of 1/20 first strand cDNA dilution
was used instead of genomic DNA. Background subtraction,
average PCR efficiency for each amplicon and N0 values were
calculated using LinRegPCR ver. 2012 software (Ruijter et al.,
2009). Expression levels for each sample and gene of interest
(GOI) were represented as N0 GOI/N0 UBI.
RESULTS
NMR Spectroscopic Analysis Uncovers
Novel Metabolites in Both HAP and LAP
Chemotypes
The natural products found in A. annua have previously been
grouped into eight broad categories, including: (i) monoterpenes;
(ii) sesquiterpenes; (iii) diterpenes, (iv) sterols and triterpenes;
(v) aliphatic hydrocarbons, alcohols, aldehydes and acids; (vi)
aromatic alcohols, ketones and acids; (vii) phenylpropanoids;
and (viii) flavonoids (Brown, 2010). In the present work we
have used the Artemis variety of A. annua as a representative
of the HAP chemotype and NCV as a representative of the
LAP chemotype (Larson et al., 2013). Our initial investigations
using NMR analysis of leaf extracts of Artemis resulted in the
isolation of 41 metabolites (6 of which were novel) representing
all eight classes of natural products (Figure 1A, Supplementary
List 1). The structures of all compounds were determined
by 1D- and 2D- NMR spectroscopy (detailed NMR data in
Supplementary Section). Novel compounds which have not
been isolated before as natural products include four new 11,13-
dihydroamorphanes: 5β-hydroperoxy-eudesma-4(15),11-diene
(4), 11-hydroxy-arteannuin I (18), 6α-hydroxy-arteannuin J
(19), arteannuin P (20), the ketal form of arteannuin Q (26)
and abeo-amorphane sesquiterpene (27). Artemisinin (22)
was the most abundant metabolite in this analysis (Figure 2,
Supplementary List 1, and Supplemental Table 1); but the
Artemis extract also contained two other sesquiterpenes:
dihydroartemisinic acid (DHAA, 8), and dihydro-epi-
deoxyarteannuin B (DHEDB, 12) in substantial amounts
(Figure 2, Supplementary List 1 and Supplemental Table 1). In
addition, a further nine known 11,13-dihydroamorphanoic acid
derivatives (α-epoxy-dihydroartemisinic acid (10); 4α,5α-epoxy-
6α-hydroxyamorphan-12-oic acid (11); dihydroarteannuin B
(14); arteannuin M (15); arteannuins H, I and J (21, 16, and 17);
deoxyartemisinin (23); and a 4,5-seco-4,5-diketo-amorphan-
12-oic acid (24) (see Figure 1A, Supplementary List 1 and
Supplemental Table 1) were also isolated as minor components
from the Artemis leaf extracts (Figure 2, Supplementary List 1
and Supplemental Table 1).
Phytochemical investigation of the NCV variety by NMR
yielded 57 metabolites, 20 of which were novel (Figure 1B
and Supplementary List 2), representing 7 of the 8 categories
above. Novel metabolites from the NCV variety are depicted
in Figure 1B and include: (E)-7-hydroxy-2,7-dimethylocta-
2,5-dien-4-one (43), (E)-7-hydroperoxy-2,7-dimethylocta-2,5-
dien-4-one (44), 6,7-epoxy-6,7-dihydro-β-farnesene (45), 6-
hydroxy-γ-humulene (48), 7α-hydroxy-artemisinic acid (52),
arteannuin R (54), arteannuin S (55), 4α, 5α-epoxy-6α-
hydroxyartemisinic acid methyl ester (57), dehydroarteannuin
L (59), epi-11-hydroxy-arteannuin I (64), artemisinic acid,
6α-peroxy ester (65), deoxyartemistene (67), arteannuin T
(69), arteannuin U (70), arteannuin V (72), arteannuin W
(73), arteannuin Y (74), isoarteannuin A (77), arteannuin
Z (78), and 3-(2-(2,5-dihydrofuran-3-yl)ethyl)-2,2-dimethyl-4-
methylenecyclohexan-1-one (79).
As might have been expected, the most striking difference
between the NCV and Artemis varieties was the almost complete
absence of artemisinin, dihydroartemisinic acid (DHAA, (8)) and
dihydro-epi-deoxyarteannuin B (DHEDB, (12)) in the former
(Supplemental Table 1). The NCV variety did, however, have
relatively high levels of three 11-13-unsaturated amorphanes,
which were found only as minor components in the Artemis
variety, namely: artemisinic acid (AA, 9), arteannuin B (ArtB,
60) and epi-deoxyarteannuin B (EDB, 13) (Figure 2 and
Supplemental Table 1). All the other amorphane sesquiterpenes
isolated and characterized from the NCV variety by NMR
shared this same trait: i.e., possession of an 11,13-unsaturated
methylene group (Figures 1B, 2 and Supplemental Table 1),
and there is an almost complete absence of 11,13-dihydro-
amorphanes from NCV, that contrasts with the abundance of
these compounds in the Artemis variety (Supplementary List
2 and Supplemental Table 1). It is interesting to note that
there are ten examples where 11,13-dihdyro/ 11,13-dehydro
amorphanolides seem to occur as “pairs” between Artemis
and NCV as depicted in Figure 2. These include: DHAA
(8)/AA (9); artemisinin (22)/artemisitene (66); dihydro-epi-
deoxyarteannuin B (12)/epi-deoxyarteannuin B (13); α-epoxy-
dihydroartemisinic acid (10)/α-epoxy-artemisinic acid (56);
dihydroarteannuin B (14)/arteannuin B (60); arteannuin M
(15)/dehydroarteannuin M (61); arteannuin I (16)/annulide
(62); arteannuin J (17)/isoannulide (63); deoxyartemsinin
(23)/deoxyartemsitene (67); and 4,5-seco-4,5-diketo-amorphan-
12-oic acid (24) and its 11,13-dehydro-analog (68). It is also
noteworthy that 9 of the 20 novel amorphane and seco-
amorphane sesquiterpenes isolated and characterized from the
NCV variety by NMR, possess an 11, 13-unsaturated methylene
group (Figures 1B, 2 and Supplementary List 2).
All the above results are consistent with a higher DBR2 activity
in the HAP chemotype compared to the LAP chemotype (Yang
et al., 2015). The relative abundances for 8 of these 10 “pairs”
are also well matched between the Artemis and NCV varieties,
suggesting a “shared” further metabolism for DHAA in Artemis
and AA in NCV. The first exception is arteannuin B (ArtB 60),
which is abundant in NCV, whilst its analog, dihydroarteannuin
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B (14), is relatively low in Artemis (Supplemental Table 1). The
second is artemisitene, the 11,13-dehydro analoge of artemisinin
(Acton and Klayman, 1985; Woerdenbag et al., 1994; Figure 1;
Supplemental Table 1) which is a minor compound in NCV,
while its “partner” artemisinin is the most abundant metabolite
in Artemis (Supplemental Table 1). These observations suggest
that while there are many parallels in the pathways that further
transform DHAA (8) and AA (9) in the HAP and LAP
chemotypes there are also some significant differences.
Metabolomic and Gene Expression Studies
Reveal Multiple Differences Between HAP
and LAP Chemotypes
Using a leaf maturation time-series, we recently demonstrated
that artemisinin levels increase gradually from juvenile to
mature leaves and remain stable during the post-harvest drying
process in Artemis HAP chemotype plants (Czechowski et al.,
2016). Using a similar time-series (which included fresh leaf
1–5 (juvenile), and 11–13 (mature) (counting from the apical
meristem); plus oven-dried whole plant-stripped leaves (dry)
from 12-week-old glasshouse-grown plants), we have now
performed UPLC- and GC-MS based metabolite profiling of
extracts from both HAP (Artemis) and LAP (NCV) chemotypes.
We found that the pathway entry–point metabolite, amorpha-
4,11-diene (A-4,11-D), is only detectable in juvenile leaves,
and at approximately 2-fold higher concentration in Artemis
as compared to NCV (Figure 3Ai; Supplemental Table 3). A
much greater difference was seen for the enzymatically-produced
artemisinin precursor, dihydroartemisinic acid (DHAA), which
was present at a 24-fold higher concentration in juvenile Artemis
leaves compared to NCV (Figure 3Aii), Supplemental Table
2). Artemisinic acid (AA) on the other hand accumulated in
NCV leaves at a 10-fold higher concentration than in Artemis
(Figure 3Aiii), Supplemental Table 1). Interestingly the levels of
AA in the young leaves of NCV variety are approximately twice
the levels of DHAA in young leaves of Artemis (Figures 3Aii,iii),
Supplemental Table 2). The levels of both DHAA and AA
dropped sharply beyond the juvenile leaf stage in Artemis
and NCV, respectively (Figures 3Aii,iii), Supplemental Table 2).
These changes in metabolite levels occur during leaf maturation
are mirrored by changes in steady state mRNA levels of
genes encoding the enzymes involved in their biosynthesis
including: amorpha-4,11-diene synthase (AMS), amorpha-4,11-
diene C-12 oxidase (CYP71AV1), artemisinic aldehyde 111,(13)
reductase (DBR2) and aldehyde dehydrogenase (ALDH1) which
are expressed at levels two to three orders of magnitude higher in
juvenile than in mature leaves (Figures 3Bi–iv).
Previous work has suggested that in vivo conversions
beyond DHAA (8) (Czechowski et al., 2016) and in vitro
conversions beyond AA (9) (Brown and Sy, 2007) are non-
enzymatic. Consistent with this, we have found that mature
leaves of NCV contain high levels of epi-deoxyarteannuin
B (EDB, 13) and arteannuin B (ArtB, 60) (Figures 3Av,vii),
Supplemental Table 2), while Artemis accumulates dihydro-
epi-deoxyarteannuin B (DHEDB, 12) and artemisinin (22)
(Figures 3Aiv,vi) Supplemental Table 2) at 20–30-fold higher
levels than NCV. Both artemisinin (22) and arteannuin B
(60) continue to accumulate in the post-harvest drying process
in Artemis and NCV respectively (Figures 3Avi,vii). Post-
harvest accumulation of artemisinin has been reported before
(Ferreira and Luthria, 2010) and it might be related to light-
dependent conversion of DHAA. However slightly different
batch specific environmental effects during drying might explain
the difference between the artemisinin accumulation pattern
shown in Figure 3Avi) and that which was previously reported
for the Artemis variety (Czechowski et al., 2016). Interestingly,
the developmental pattern of DHEDB (12) accumulation in
Artemis leaves is different to its 11,13-dehydro analog, EDB (13)
in NCV leaves. DHEDB (12) follows the same accumulation
pattern as for artemisinin (22) in Artemis (Figures 3Aiv,vi);
whereas EDB (13) is found predominantly in juvenile leaves of
the NCV variety (Figure 3Av). We have found that production
of the artemisinin 11,13-dehydro analog, artemisitene (66) in
NCV parallels the accumulation of artemisinin (22) in Artemis
(Supplemental Table 2), albeit at very much reduced levels.
The levels of deoxyartemisinin (23), another product of non-
enzymatic conversion of DHAA through the DHAA allylic
hydroperoxide, increase during dry leaf storage, accumulating to
0.1% leaf dry weight (Supplemental Table 2), which is consistent
with previous findings (Czechowski et al., 2016). This process
is paralleled by accumulation of deoxyartemisitene (67) (the
11,13-dehydro analog of deoxyartemisinin) in the NCV variety
(Supplemental Table 2).
RT-qPCR analysis confirmed the expression level for DBR2 to
be significantly repressed (8-fold lower) in the juvenile leaves of
NCV compared to Artemis, which is consistent with previous
findings (Yang et al., 2015). Interestingly, DBR2 transcript
abundance had decreased to the same levels in mature leaves
of both chemotypes (Figure 3Biii), highlighting the importance
of developmental timing in regulating flux and partitioning of
sesquiterpene metabolites. More surprisingly,ALDH1 expression
is increased in juvenile leaves (2.4-fold) and further increased
in mature leaves (40-fold) of NCV (Figure 3Biv) compared to
Artemis. Thus it would appear that in addition to DBR2 being
down-regulated in the NCV (LAP) chemotype, ALDH1 is up-
regulated at the transcriptional level. This could also account
for the increase in flux into artemisinic acid and the arteannuin
B branch of sesquiterpene metabolism. The major differences
in metabolite levels and gene expression between Artemis and
NCV varieties for the artemisinin biosynthetic pathway are
summarized in Figure 3C.
NMR analysis revealed that metabolite differences between
Artemis and NCV are not restricted to artemisinin-related
sesquiterpenes. Monoterpenes also vary between the two
chemotypes, with for example camphor being most abundant
in Artemis while artemisia ketone level is much more abundant
in NCV (Supplemental Table 1). Unfortunately, NMR-analysis
could only provide approximate information about the relative
abundance of the metabolites, therefore metabolite content of
both chemotypes was also studied by GC- and UPLC-MS
(Supplemental Tables 2, 3). We were able to detect 75 unique
compounds in three leaf types byUPLC-MS of which annotations
were assigned to 30 compounds based on NMR-verified
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standards as described in the Materials and Methods. The
majority of the known compounds were sesquiterpenes and
flavonoids. GC-MS detected 202 unique compounds in juvenile
and mature leaves, of which 33 had assigned annotations. The
majority of known GC-MS-detected compounds were mono-
and sesquiterpenes. Using principal component analysis, it can
be seen that the overall metabolite profile of NCV appears
strikingly different to that of Artemis; as much as the difference
between the profiles between juvenile leaves and mature- and/or
dry leaves. In fact, UPLC- and GC-MS PCA plots show four
distinct clusters (Figures 4A and B). Developmental differences
are most apparent in juvenile leaf tissue, which show the highest
abundance of most of the terpenes described below (Figure 4,
Supplemental Tables 2 and 3). Our findings that the metabolite
profiles in Artemis and NCV young leaf tissues are considerably
different to mature and dry leaves in both varieties are consistent
with our previous findings (Czechowski et al., 2016).
There are a number of compounds specifically produced
by NCV, mostly in low quantities (Supplemental Tables 2 and
3) which have known medicinal use including, for example,
isofraxidin (39), which is five-fold more abundant in the juvenile
leaves of NCV as compared to Artemis (Supplemental Table 2).
Isofraxidin is a coumarin with anti-inflammatory (Niu et al.,
2012) and anti-tumor activities (Yamazaki and Tokiwa, 2010).
Artemisia ketone (42), an irregular monoterpene found in
the essential oil from various A. annua varieties displaying
antifungal activities (Santomauro et al., 2016) is the most
abundant volatile in the juvenile and mature leaves of NCV,
but virtually absent in Artemis (Supplemental Table 3). The
juvenile and mature leaves of Artemis accumulate velleral,
a sesquiterpene dialdehyde which has proposed antibacterial
activities (Anke and Sterner, 1991), which is virtually absent
in the NCV variety (Supplemental Table 3). GC-MS analysis
further revealed that several major montoerpenes are also more
abundant in juvenile and mature leaves of Artemis, including
camphor (3.7-fold higher), camphene (3.4-fold higher), borneol,
(16-fold higher), α-pinene (4.6-fold higher) and 1,8-cineole (8-
fold higher) (Supplemental Table 3). Some minor monoterpenes
detected in the Artemis variety, such as: α-myrcene, α –
terpinene, chrysanthenone and α-copaene, are virtually absent
in young and mature NCV leaves (Supplemental Table 3). A
few striking differences were noted for the level of artemisinin-
unrelated abundant sesquiterpenes, such as sabinene and cis-
sabinene hydrate, which are 7.5- and 38-fold (respectively) more
abundant in Artemis young leaves than in NCV (Supplemental
Table 3). Germacrene A is a sesquiterpene common across the
Asteraceae family for which it has been demonstrated that its
downstream metabolism parallels artemisinic acid biosynthetic
pathway (Nguyen et al., 2010). Germacrene A levels are 32- and
17-fold higher in NCV young and mature leaves (respectively)
making it the most abundant volatile in mature and the second
most abundant in young leaves of the NCV variety.
Visualization of the loadings from the multivariate analyses
were used to identify the most influential compounds
discriminating chemotypes. PC1 loading plots identified
18 compounds from UPLC- and 20 from GC-MS analysis
(Supplementary Figure 1), which were used to create the
heatmaps presented in Figure 5. The vast majority of the most
influential compounds distinguishing between two chemotypes
from UPLC-MS analysis were the amorphane sesquiterpenes
(Figure 5A). The mono- and sesquiterpenes mentioned above
(together with some unknown compounds) were the most
influential GC-MS-detectable metabolites distinguishing
between two chemotypes (Figure 5B).
Morphological Difference Between Two
Chemotypes of A. annua
In addition to having very distinct phytochemical compositions
the F1 Artemis HAP chemotype and the open pollinated NCV
LAP chemotype varieties also have very distinct morphological
features (Figure 6). Most strikingly, NCV is much taller with
longer internodes but produces smaller leaves than Artemis. The
density of glandular secretory trichomes, the site of artemisinin
synthesis, is similar for both varieties (Figure 6E), which is
consistent with the main difference in artemisinin production
being due to an alteration in metabolism rather than trichome
density. A. annua varieties typically require short day length for
flowering (Wetzstein et al., 2014), but we observed that NCV,
unlike Artemis, can also flower under long days. However, the
two chemotypes do cross-pollinate and produce viable progeny.
DISCUSSION
This manuscript presents the first detailed phytochemical
comparison of high- (HAP) and low-artemisinin producing
(LAP) chemotypes chemotypes of A. annua.
Twenty six of the 85 metabolites that have been characterized
by NMR from the HAP and LAP varieties of A. annua in
this study are novel as natural products (all are mono- and
sesquiterpenes). And of these, 19 are amorphane sesquiterpenes,
which is the most diverse and the most abundant sub-
class (Supplemental Table 1, Supplementary Lists 1 and 2).
The majority of these amorphane sesquiterpenes are highly
oxygenated with structures that would be consistent with further
oxidative metabolism of DHAA (11,13-saturated, 8) in the
HAP variety and AA (11,13-unsaturated, 9) in the LAP variety
(Figures 1 and 2, Supplemental Table 1, Supplementary Lists 1
and 2).
UPLC- and GC-MS analysis of leaf developmental series
also revealed amorphanes either saturated or unsaturated at the
11,13-position in the HAP and LAP chemotypes, respectively
(Figure 3, Supplemental Table 2). This observation is consistent
with the expression of theDBR2 gene, which encodes the enzyme
responsible for reducing the 11,13-double bond of artemisinic
aldehyde (the precursor for 11,13-dihydroamorphane/cadinane
sesquiterpenes), being strongly down-regulated in juvenile leaves
of NCV (Figure 3Biii). These findings are in complete agreement
with the recent report on reduced levels of DBR2 in LAP
compared with HAP chemotypes (Yang et al., 2015). In addition
to altered expression of DBR2, we also found that expression
of aldehyde dehydrogenase (ALDH1), which converts artemsinic
and dihydroartemsinic aldehydes to their respective acids (Teoh
et al., 2009), is significantly elevated in juvenile and mature leaves
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of NCV compared to Artemis. This may lead to an increased
flux from A-4,11-D to AA (8) in NCV when compared with
flux from A-4,11-D to DHAA (9) in Artemis which is reflected
by a significantly higher concentration of AA found in juvenile
leaves of NCV when compared to the concentration of DHAA
in young Artemis leaves (Figures 3Aii,iii). The elevated flux
from A-4,11-D to AA (8) might also explain lower levels of
A-4,11-D found in juvenile leaves of NCV when compared
with Artemis (Figure 3Ai) as the expression of amorpha-4,11-
diene synthase (AMS) is at very similar level in both varieties
(Figure 3Bi). We have also observed that the NCV (LAP) variety
expresses a sequence variant of amorpha-4,11-diene C-12 oxidase
(CYP71AV1) with a 7 amino acid N-extension (Supplementary
Figure 2). This LAP-chemotype associated sequence variant upon
transient expression in Nicotiana benthamiana, in combination
with the other artemisinin pathway genes resulted in a
qualitatively different product profile (“chemotype”); that is a
shift in the ratio between the unsaturated and saturated (dihydro)
branch of the pathway (Ting et al., 2013). That result strongly
suggests the two distinct isoforms of CYP71AV1 are associated
with HAP- and LAP-branches of the artemisinin pathway in
Artemisia annua (Figure 3C). A number of previous reports
have described the existence of LAP- and HAP-chemotypes of
A. annua arising from distinct geographical locations (Lommen
et al., 2006; Arsenault et al., 2010; Larson et al., 2013). It would be
interesting to establish if sequence variant forms of CYP71AV1
and differential expression of DBR2 are generally found between
these other LAP- and HAP-chemotypes.
Recent attempts to constitutively overexpress DBR2 in
transgenic A. annua resulted in doubling of the artemisinin
concentration, which was also accompanied by a significant
increase in DHAA and AA production (Yuan et al., 2015).
Improvements in artemisinin concentration obtained in these
experiments by Yuan et al. were significantly better than those
achieved by constitutive co-expression of CYP71AV1 and CPR
(Shen et al., 2012), where the LAP-sequence variant ofCYP71AV1
was overexpressed in transgenicA. annua. Our results suggest the
glandular trichome-targeted overexpression of DBR2 specifically
in the HAP-type of CYP71AV1 might be the more efficient route
to improving artemisinin production in transgenic A. annua.
Although arteannuin B (ArtB) was almost entirely absent
from young leaf tissue of the NCV variety, as leaves matured
it accumulated to become the most abundant natural product
(Figure 3Avii). This observation seemed to parallel both the
accumulation of artemisinin in the mature tissues of Artemis
that has been noted above (Figure 3vi), as well as the recently
described accumulation of arteannuin X in the mature leaves
of the cyp71av1-1 mutant of A. annua (Czechowski et al.,
2016). The accumulation of both artemisinin and arteannuin
X are considered to be the result of non-enzymatic processes,
in which the 4,5-double bond of a precursor sesquiterpene
undergoes spontaneous autoxidation with molecular oxygen to
produce a tertiary allylic hydroperoxide. The metabolic fate of
this hydroperoxide is critically dependent on the identity of
the precursor—and in particular on the functionality contained
elsewhere in the molecule. Thus, in the case of Artemis, the
precursor is DHAAwhich presents a 12-carboxylic acid group (as
well as saturation at the 11,13-position); whilst for the cyp71av1-1
mutant it is amorpha-4,11-diene (A-4,11-D), which presents a
11,13-double bond (Czechowski et al., 2016). Both in vivo and in
vitro experiments indicate that this difference in functionality is
the basis of why DHAA-OOH (the tertiary allylic hydroperoxide
from DHAA) is converted to artemisinin, whereas A-4,11-D-
OOH is converted to arteannuin X (Czechowski et al., 2016).
We therefore hypothesized that the conversion of artemisinic
acid (AA) to artemisitene (ArtB) in NCV may also be a non-
enzymatic process, paralleling the conversion of DHAA into
artemisinin in Artemis (Supplementary Figures 3A and B) and of
amorpha-4,11-diene to arteannuin X in the cyp71av1-1 mutant
(Czechowski et al., 2016). The tertiary allylic hydroperoxide
from artemisinic acid (AA-OOH) differs from the two foregoing
examples in that it incorporates both a 12-carboxylic acid
group and unsaturation at the 11,13-position. In support of
this hypothesis, when a sample of AA-OOH (produced by
photosensitized oxygenation of AA; and purified by HPLC) was
left unattended for several weeks, it was indeed found to have
been converted predominantly to ArtB (albeit at a rate that was
significantly slower than for the conversion of DHAA-OOH to
artemisinin). This unexpected transformation is mostly simply
explained by attack of the 12-carboxylic acid group at the allylic
position of the hydroperoxide, as is shown in Supplementary
Figure 3A. Further studies will be required to explain why it
should be that this (apparently) rather subtle modification to the
12-CO2H group (i.e., the introduction of 11,13-unsaturation in
AA-OOH) has resulted in such a radically different pathway, as
compared with DHAA-OOH.
The second most abundant product of AA-OOH
conversion is epi-deoxyarteannuin B (EDB), which accumulates
predominantly in young leaves of NCV. The EDB accumulation
pattern is therefore different to DHEDB (the 11,13-saturated
anaolog), where the latter’s concentration rises from top to
mature and dry leaves in Artemis, broadly following the
accumulation pattern of artemisinin. We have proposed that
the spontaneous conversions of AA into EDB and DHAA
into DHEDB progress via very similar molecular mechanisms
(Supplementary Figures 3C and D). Interestingly we have
observed very little EDB arising from the spontaneous
conversions of AA-OOH described above, which was
predominantly converted to ArtB. It is known that a hydrophobic
(lipophilic) environment promotes conversions of DHAA-OOH
into artemisinin whereas an aqueous, acidic medium promotes
DHAA-OOH conversions to DHEDB (Brown and Sy, 2004).
This may also explain the very minor conversion of AA-
OOH into EDB which was carried out in a hydrophobic
environment (deuterated chloroform), and which promoted
AA-OOH conversions to ArtB. This highlights the parallels
between artemisinin and arteannuin B biogenesis shown in
Supplementary Figures 3A and B. It also suggests that in vivo
conversions of AA-OOH to EDB requires an aqueous intra-
cellular environment, which might be expected to be present
in young leaf trichomes, but less so in mature leaf trichomes
where the sub-apical hydrophobic cavities are predominant
(Ferreira and Janick, 1995), or upon cell dehydration (in dried
leaf material).
Differences between the LAP and HAP chemotypes extended
well beyond artemisinin-related sequiterpenes to other classes
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of terpenes (Figures 4 and 5, Supplemental Tables 1–3). This
divergence at the level of metabolism is not that surprising given
that these chemotypes also exhibit significant differences in their
morphology (Figure 6). Artemis is an F1 hybrid derived from
HAP parents of East Asian origin (Delabays et al., 2001) while
NCV is an open-pollinated variety of European origin (personal
communication with Dr. Michael Schwerdtfeger, curator of
Botanical Garden at the University of Göttingen, Germany). This
is consistent with the general trend for the A. annua varieties of
European andNorth American origin whichmostly represent the
LAP chemotype and the majority of East-Asian origin varieties
which represent the HAP chemotype (Wallaart et al., 2000),
Details of the genetic divergence of these varieties remains a topic
for further investigation that could reveal further insight into the
sesquiterpene flux into different end products.
CONCLUSION
This first comparative phytochemical analysis of high- (HAP)
and LAP chemotypes of A. annua has resulted in the
characterization of over 85 natural products by NMR, 26 of
which have not previously been described in A. annua. We have
also shown that the vast majority of amorphane sesquiterpenes
are unsaturated at the 11,13-position in the LAP-chemotype as
opposed to the majority of them being saturated at the 11,13-
position in the HAP-chemotype. This is explained by existence
of two sequence variants of CYP71AV1 in the two investigated
chemotypes and differential expression of the key branching
enzyme in the artemisinin pathway, namely artemisinic aldehyde
1 11 (13) reductase (DBR2). By highlighting the main points of
difference between HAP and LAP chemotypes our findings will
help inform strategies for the future improvement of artemisinin
production in either A. annua or heterologous hosts.
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